Empowering community oncology to advance patient care
Multiple Myeloma / ASH Review Conference Being Converted to Virtual Format
If you already registered for this event, your registration will be automatically converted to the virtual program – no further action is needed on your behalf.
If you were planning to attend this program and you already booked your travel and lodging accommodations through ION, your reservation will be automatically cancelled. If you made accommodations outside of the room block, you will have to cancel independently.
The MM / ASH Review Conference will now be divided into two segments over two half days: Friday, January 21 and Saturday, January 22.
We will communicate additional details as soon as they become available.
Treating with TIBSOVO: A targeted therapeutic option for patients with R/R mIDH1 AML
Listen to a discussion between Jonathan Abbas, MD, and Mark Levis, MD, PhD.
Please listen to additional safety information for TIBSOVO® (ivosidenib tablets) at the end of this presentation. Please visit TibsovoPro.com to review the Full Prescribing Information, including BOXED WARNING.
We help community oncology practices thrive
We help you focus on what matters most—
Optimize access and purchasing power
Navigate industry changes
Advance the quality of patient care
Elevate business performance
Your Smart GPO
What does it mean to be a Smart GPO? For us, it means using data and actionable insights to support your practice in the transition to value-based care. It means providing analytics tools to help you align with national guidelines. And it means using empirical evidence to put patient outcomes at the heart of your practice's health and sustainability.
When you join our Smart GPO, you become part of a network of community oncology practices making data-backed decisions to advance the quality of patient care. That's having a smart partner in your corner.